Artal Group as of Sept. 30, 2017
Portfolio Holdings for Artal Group
Artal Group holds 98 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Blue Buffalo Pet Prods | 42.7 | $2.5B | 88M | 28.35 | |
Weight Watchers International | 22.1 | $1.3B | 29M | 43.55 | |
Lexicon Pharmaceuticals (LXRX) | 12.2 | $707M | 58M | 12.29 | |
Bank of America Corporation (BAC) | 4.3 | $250M | 9.9M | 25.34 | |
Incyte Corporation (INCY) | 1.1 | $64M | 550k | 116.74 | |
Goldman Sachs (GS) | 0.8 | $47M | 200k | 237.19 | |
Nektar Therapeutics (NKTR) | 0.8 | $44M | 1.9M | 24.00 | |
Bristol Myers Squibb (BMY) | 0.7 | $41M | 650k | 63.74 | |
Allergan | 0.7 | $41M | 200k | 204.95 | |
Wells Fargo & Company (WFC) | 0.6 | $36M | 650k | 55.15 | |
Array BioPharma | 0.5 | $31M | 2.5M | 12.30 | |
Agios Pharmaceuticals (AGIO) | 0.5 | $30M | 450k | 66.75 | |
Alnylam Pharmaceuticals (ALNY) | 0.5 | $29M | 250k | 117.49 | |
International Business Machines (IBM) | 0.5 | $29M | 200k | 145.08 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $28M | 300k | 93.07 | |
Acceleron Pharma | 0.5 | $26M | 700k | 37.32 | |
Amicus Therapeutics (FOLD) | 0.4 | $26M | 1.7M | 15.08 | |
Bluebird Bio (BLUE) | 0.4 | $25M | 185k | 137.35 | |
Neurocrine Biosciences (NBIX) | 0.4 | $25M | 400k | 61.28 | |
American Airls (AAL) | 0.4 | $24M | 500k | 47.49 | |
Radius Health | 0.4 | $23M | 600k | 38.55 | |
Beigene (BGNE) | 0.4 | $23M | 225k | 103.46 | |
BlackRock (BLK) | 0.4 | $22M | 50k | 447.10 | |
Citigroup (C) | 0.4 | $22M | 300k | 72.74 | |
MetLife (MET) | 0.4 | $21M | 400k | 51.95 | |
Gilead Sciences (GILD) | 0.3 | $20M | 250k | 81.02 | |
Intel Corporation (INTC) | 0.3 | $19M | 500k | 38.08 | |
Amgen (AMGN) | 0.3 | $19M | 100k | 186.45 | |
Medicines Company | 0.3 | $19M | 500k | 37.04 | |
Global Blood Therapeutics In | 0.3 | $17M | 550k | 31.05 | |
Juno Therapeutics | 0.3 | $16M | 350k | 44.86 | |
Morgan Stanley (MS) | 0.2 | $15M | 300k | 48.17 | |
Teradyne (TER) | 0.2 | $13M | 350k | 37.29 | |
Ironwood Pharmaceuticals (IRWD) | 0.2 | $13M | 817k | 15.77 | |
Tesaro | 0.2 | $13M | 100k | 129.11 | |
58 Com Inc spon adr rep a | 0.2 | $13M | 200k | 63.14 | |
Horizon Pharma | 0.2 | $13M | 1.0M | 12.68 | |
Avexis | 0.2 | $12M | 120k | 96.73 | |
Agenus (AGEN) | 0.2 | $11M | 2.5M | 4.41 | |
Ignyta | 0.2 | $11M | 900k | 12.35 | |
Atara Biotherapeutics (ATRA) | 0.2 | $9.9M | 600k | 16.55 | |
Clovis Oncology | 0.2 | $9.5M | 115k | 82.40 | |
Sarepta Therapeutics (SRPT) | 0.2 | $9.1M | 200k | 45.36 | |
Sage Therapeutics (SAGE) | 0.2 | $9.3M | 150k | 62.30 | |
Seres Therapeutics (MCRB) | 0.1 | $8.8M | 550k | 16.04 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $7.3M | 1.5M | 4.85 | |
Alder Biopharmaceuticals | 0.1 | $6.1M | 500k | 12.25 | |
Audentes Therapeutics | 0.1 | $5.6M | 200k | 28.01 | |
Ac Immune Sa (ACIU) | 0.1 | $5.6M | 500k | 11.17 | |
Seattle Genetics | 0.1 | $5.4M | 100k | 54.41 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $5.3M | 160k | 32.95 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $5.2M | 150k | 34.95 | |
Achillion Pharmaceuticals | 0.1 | $4.5M | 1.0M | 4.49 | |
Accelr8 Technology | 0.1 | $4.5M | 200k | 22.45 | |
Tg Therapeutics (TGTX) | 0.1 | $4.7M | 400k | 11.85 | |
Vital Therapies | 0.1 | $4.4M | 875k | 5.05 | |
Elf Beauty (ELF) | 0.1 | $4.5M | 200k | 22.55 | |
Achaogen | 0.1 | $4.0M | 250k | 15.95 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $4.1M | 500k | 8.19 | |
Intellia Therapeutics (NTLA) | 0.1 | $4.3M | 175k | 24.85 | |
BioCryst Pharmaceuticals (BCRX) | 0.1 | $3.4M | 650k | 5.24 | |
BioTime | 0.1 | $3.6M | 1.3M | 2.84 | |
Newlink Genetics Corporation | 0.1 | $3.6M | 350k | 10.18 | |
Verastem | 0.1 | $3.5M | 750k | 4.70 | |
Chemocentryx | 0.1 | $3.7M | 500k | 7.42 | |
Macrogenics (MGNX) | 0.1 | $3.7M | 200k | 18.48 | |
Zafgen | 0.1 | $3.5M | 1.0M | 3.52 | |
Dynavax Technologies (DVAX) | 0.1 | $3.2M | 150k | 21.50 | |
Axovant Sciences | 0.1 | $3.4M | 500k | 6.88 | |
D Stemline Therapeutics | 0.1 | $2.8M | 250k | 11.10 | |
Chimerix (CMRX) | 0.1 | $2.6M | 500k | 5.25 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $2.7M | 50k | 53.26 | |
Glycomimetics (GLYC) | 0.1 | $2.8M | 203k | 13.99 | |
Calithera Biosciences | 0.1 | $2.8M | 175k | 15.75 | |
Fibrogen (FGEN) | 0.1 | $2.7M | 50k | 53.80 | |
Cellectis S A (CLLS) | 0.1 | $2.8M | 100k | 28.45 | |
Jounce Therapeutics | 0.1 | $3.1M | 200k | 15.58 | |
Five Prime Therapeutics | 0.0 | $2.0M | 50k | 40.92 | |
Xencor (XNCR) | 0.0 | $2.3M | 100k | 22.92 | |
Bellicum Pharma | 0.0 | $2.3M | 200k | 11.55 | |
Aduro Biotech | 0.0 | $2.1M | 200k | 10.65 | |
Celldex Therapeutics | 0.0 | $1.9M | 675k | 2.86 | |
Minerva Neurosciences | 0.0 | $1.9M | 251k | 7.60 | |
Kura Oncology (KURA) | 0.0 | $1.5M | 100k | 14.95 | |
Syndax Pharmaceuticals (SNDX) | 0.0 | $1.8M | 153k | 11.70 | |
Noveliontherapeuti.. | 0.0 | $1.8M | 256k | 7.03 | |
Biohaven Pharmaceutical Holding | 0.0 | $1.9M | 50k | 37.38 | |
Versartis | 0.0 | $980k | 400k | 2.45 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.0 | $1.3M | 250k | 5.05 | |
Corbus Pharmaceuticals Hldgs | 0.0 | $1.1M | 150k | 7.15 | |
Nantkwest | 0.0 | $1.2M | 225k | 5.48 | |
Dimension Therapeutics | 0.0 | $1.4M | 235k | 6.00 | |
Oncocyte | 0.0 | $1.1M | 150k | 7.55 | |
Miragen Therapeutics | 0.0 | $915k | 100k | 9.15 | |
Argenx Se (ARGX) | 0.0 | $1.2M | 54k | 22.62 | |
Krystal Biotech (KRYS) | 0.0 | $997k | 100k | 9.97 | |
Novavax | 0.0 | $570k | 500k | 1.14 | |
Xenon Pharmaceuticals (XENE) | 0.0 | $443k | 150k | 2.95 |